Klingenstein Fields & CO LP Johnson & Johnson Transaction History

Klingenstein Fields & CO LP

  • $2.39 Billion
  • Q2 2024

A detailed history of Klingenstein Fields & CO LP transactions in Johnson & Johnson stock. As of the latest transaction made, Klingenstein Fields & CO LP holds 247,010 shares of JNJ stock, worth $41 Million. This represents 1.51% of its overall portfolio holdings.

Number of Shares
247,010
Previous 249,558 1.02%
Holding current value
$41 Million
Previous $39.5 Million 8.55%
% of portfolio
1.51%
Previous 1.65%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 01, 2024
SELL
$144.38 - $157.78 $367,880 - $402,023
-2,548 Reduced 1.02%
247,010 $36.1 Million
Q1 2024

Apr 29, 2024
SELL
$155.22 - $162.74 $1.04 Million - $1.09 Million
-6,694 Reduced 2.61%
249,558 $39.5 Million
Q4 2023

Feb 01, 2024
SELL
$145.6 - $158.88 $1.85 Million - $2.02 Million
-12,727 Reduced 4.73%
256,252 $40.2 Million
Q3 2023

Oct 27, 2023
BUY
$155.75 - $174.48 $174,440 - $195,417
1,120 Added 0.42%
268,979 $41.9 Million
Q2 2023

Aug 01, 2023
SELL
$154.35 - $166.11 $543,620 - $585,039
-3,522 Reduced 1.3%
267,859 $44.3 Million
Q1 2023

Apr 28, 2023
SELL
$151.05 - $180.26 $697,397 - $832,260
-4,617 Reduced 1.67%
271,381 $42.1 Million
Q4 2022

Feb 02, 2023
SELL
$160.2 - $179.79 $816,219 - $916,030
-5,095 Reduced 1.81%
275,998 $48.8 Million
Q3 2022

Oct 28, 2022
BUY
$161.33 - $179.52 $363,476 - $404,458
2,253 Added 0.81%
281,093 $45.9 Million
Q2 2022

Aug 01, 2022
SELL
$168.19 - $186.01 $230,924 - $255,391
-1,373 Reduced 0.49%
278,840 $49.5 Million
Q1 2022

Apr 27, 2022
SELL
$158.14 - $179.59 $494,345 - $561,398
-3,126 Reduced 1.1%
280,213 $49.7 Million
Q4 2021

Jan 31, 2022
SELL
$155.93 - $173.01 $1.94 Million - $2.16 Million
-12,461 Reduced 4.21%
283,339 $48.5 Million
Q3 2021

Oct 26, 2021
SELL
$161.5 - $179.47 $1.18 Million - $1.31 Million
-7,324 Reduced 2.42%
295,800 $47.8 Million
Q2 2021

Jul 26, 2021
SELL
$159.48 - $171.07 $474,452 - $508,933
-2,975 Reduced 0.97%
303,124 $49.9 Million
Q1 2021

Apr 29, 2021
SELL
$153.07 - $170.48 $19.7 Million - $21.9 Million
-128,698 Reduced 29.6%
306,099 $50.3 Million
Q4 2020

Feb 02, 2021
SELL
$137.11 - $157.38 $22.7 Million - $26.1 Million
-165,687 Reduced 27.59%
434,797 $68.4 Million
Q3 2020

Oct 30, 2020
SELL
$140.38 - $153.83 $983,923 - $1.08 Million
-7,009 Reduced 1.15%
600,484 $89.4 Million
Q2 2020

Aug 03, 2020
SELL
$128.81 - $155.51 $237,783 - $287,071
-1,846 Reduced 0.3%
607,493 $85.4 Million
Q1 2020

May 07, 2020
SELL
$111.14 - $153.99 $491,572 - $681,097
-4,423 Reduced 0.72%
609,339 $79.9 Million
Q4 2019

Feb 04, 2020
BUY
$127.5 - $146.44 $9.65 Million - $11.1 Million
75,668 Added 14.06%
613,762 $89.5 Million
Q3 2019

Nov 01, 2019
BUY
$126.95 - $142.14 $244,759 - $274,045
1,928 Added 0.36%
538,094 $69.6 Million
Q2 2019

Aug 12, 2019
SELL
$131.15 - $144.24 $820,999 - $902,942
-6,260 Reduced 1.15%
536,166 $74.7 Million
Q1 2019

Apr 29, 2019
SELL
$125.72 - $139.79 $31.5 Million - $35 Million
-250,204 Reduced 31.57%
542,426 $75.8 Million
Q4 2018

Jan 22, 2019
SELL
$122.84 - $147.84 $1.38 Million - $1.66 Million
-11,231 Reduced 1.4%
792,630 $102 Million
Q3 2018

Nov 01, 2018
SELL
$121.58 - $142.88 $8.24 Million - $9.68 Million
-67,754 Reduced 7.77%
803,861 $111 Million
Q2 2018

Jul 26, 2018
SELL
$119.4 - $131.76 $442,615 - $488,434
-3,707 Reduced 0.42%
871,615 $106 Million
Q1 2018

May 01, 2018
SELL
$125.1 - $148.14 $2.05 Million - $2.42 Million
-16,351 Reduced 1.83%
875,322 $112 Million
Q4 2017

Jan 30, 2018
SELL
$131.22 - $143.62 $1.73 Million - $1.89 Million
-13,194 Reduced 1.46%
891,673 $125 Million
Q3 2017

Nov 01, 2017
BUY
$129.47 - $135.38 $117 Million - $123 Million
904,867
904,867 $118 Million

Others Institutions Holding JNJ

# of Institutions
4,161
Shares Held
1.69B
Call Options Held
12.5M
Put Options Held
10.3M
View Full List

About JOHNSON & JOHNSON

JNJ Quotes by TradingView
  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $434B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Klingenstein Fields & CO LP Portfolio

Follow Klingenstein Fields & CO LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Klingenstein Fields & CO LP, based on Form 13F filings with the SEC.

News

Stay updated on Klingenstein Fields & CO LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email